Literature DB >> 23982577

Defining patients' knowledge and perceptions of vaginal mesh surgery.

Lindsay K Brown1, Dee E Fenner, Mitchell B Berger, John O L Delancey, Daniel M Morgan, Divya A Patel, Megan O Schimpf.   

Abstract

OBJECTIVE: Given recent government investigations and media coverage of the controversy regarding mesh surgery, we sought to define patients' knowledge and perceptions of vaginal mesh surgery. STUDY
DESIGN: An anonymous survey was distributed to a convenience sample of new patients at urogynecology and female urology clinics at a single medical center during April to June 2012. The survey assessed patients' demographics, information sources, and beliefs and concerns regarding mesh surgery. The Fisher's exact test was used to identify predictors of patients' beliefs regarding mesh. Logistic and linear regressions were used to identify predictors of aversion to surgery and higher concern regarding future surgery.
RESULTS: One hundred sixty-four women completed the survey; 62.2% (102/164) indicated knowledge of mesh surgery for prolapse and/or incontinence and were included in subsequent analyses. The mean ± SD age was 58.0 ± 12.5 years, and 24.5% reported prior mesh surgery. The most common information source was television commercials (57.8%); only 23.5% of the women reported receiving information from a medical professional. Participants indicated the following regarding vaginal mesh: class-action lawsuit in progress (55/102 [54.0%]), causes pain (47/102 [47.1%]), possibility of rejection (35/102 [34.3%]), can cause bleeding and become exposed vaginally (30/102 [29.4%]), and should be removed owing to recall (28/102 [27.5%]). Of these women, 22.1% (19/86) indicated they would not consider mesh surgery. On multivariable logistic regression, level of concern, information from friends/family, and knowledge of class-action lawsuit predicted aversion to mesh surgery.
CONCLUSION: Nearly two thirds of new patients had knowledge of vaginal mesh surgery. We identified considerable misinformation and aversion to future mesh surgery among these women.

Entities:  

Mesh:

Year:  2013        PMID: 23982577      PMCID: PMC4102428          DOI: 10.1097/SPV.0b013e31829ff765

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  5 in total

1.  Dangerous devices: most medical implants have never been tested for safety.

Authors: 
Journal:  Consum Rep       Date:  2012-05

2.  Words of wisdom. Re: FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence.

Authors:  Firouz Daneshgari
Journal:  Eur Urol       Date:  2009-05       Impact factor: 20.096

Review 3.  Impact of internet use on health-related behaviors and the patient-physician relationship: a survey-based study and review.

Authors:  Suzy A Iverson; Kristin B Howard; Brian K Penney
Journal:  J Am Osteopath Assoc       Date:  2008-12

4.  Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010.

Authors:  Lisa Rogo-Gupta; Larissa V Rodriguez; Mark S Litwin; Thomas J Herzog; Alfred I Neugut; Yu-Shiang Lu; Shlomo Raz; Dawn L Hershman; Jason D Wright
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

5.  Trends in use of surgical mesh for pelvic organ prolapse.

Authors:  Michele Jonsson Funk; Autumn L Edenfield; Virginia Pate; Anthony G Visco; Alison C Weidner; Jennifer M Wu
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

  5 in total
  12 in total

1.  Female urinary incontinence health information quality on the Internet: a multilingual evaluation.

Authors:  Ishani Saraswat; Robert Abouassaly; Peter Dwyer; Damien M Bolton; Nathan Lawrentschuk
Journal:  Int Urogynecol J       Date:  2015-09-09       Impact factor: 2.894

Review 2.  Canadian Urological Association position statement on the use of transvaginal mesh.

Authors:  Blayne Welk; Kevin V Carlson; Richard J Baverstock; Stephen S Steele; Gregory G Bailly; Duane R Hickling
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

Review 3.  Making surgery safer through adequate communication with the stakeholders: vaginal slings.

Authors:  Sandra Elmer; Janelle Brennan; Rebecca Mathieson; Briony Norris; Marcus Carey; Caroline Dowling
Journal:  World J Urol       Date:  2019-07-04       Impact factor: 4.226

Review 4.  The role of information technology (apps) in FPMRS.

Authors:  Jacquelyn Gonka; Jason Kim
Journal:  Curr Urol Rep       Date:  2015-02       Impact factor: 3.092

5.  Rate of Pelvic Organ Prolapse Surgery Among Privately Insured Women in the United States, 2010-2013.

Authors:  Anne G Sammarco; Carolyn W Swenson; Neil S Kamdar; Emily K Kobernik; John O L DeLancey; Brahmajee Nallamothu; Daniel M Morgan
Journal:  Obstet Gynecol       Date:  2018-03       Impact factor: 7.661

6.  Evaluation of the local carcinogenic potential of mesh used in the treatment of female stress urinary incontinence.

Authors:  Brian J Linder; Emanuel C Trabuco; Daniel A Carranza; John B Gebhart; Christopher J Klingele; John A Occhino
Journal:  Int Urogynecol J       Date:  2016-02-10       Impact factor: 2.894

7.  Defining Patient Knowledge and Perceptions of Vaginal Pessaries for Prolapse and Incontinence.

Authors:  Lindsay K Brown; Dee E Fenner; John O L DeLancey; Megan O Schimpf
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Mar-Apr       Impact factor: 2.091

Review 8.  Midurethral slings in the mesh litigation era.

Authors:  John Chang; Dominic Lee
Journal:  Transl Androl Urol       Date:  2017-07

9.  Temporal Trends of Urogynecologic Mesh Reports to the U.S. Food and Drug Administration.

Authors:  Jessica C Sassani; Amanda M Artsen; Pamela A Moalli; Megan S Bradley
Journal:  Obstet Gynecol       Date:  2020-05       Impact factor: 7.623

10.  Knowledge of pelvic organ prolapse in patients and their information-seeking preferences: comparing Vienna and Moscow.

Authors:  Polina Lyatoshinskaya; D Gumina; A Popov; M Koch; M Hagmann; W Umek
Journal:  Int Urogynecol J       Date:  2016-04-26       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.